Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates
Portfolio Pulse from
Corcept Therapeutics (CORT) reported Q4 earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.37. This is a decrease from $0.28 per share a year ago.
February 27, 2025 | 12:15 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Corcept Therapeutics reported Q4 earnings of $0.26 per share, missing estimates and showing a decline from last year. This could negatively impact the stock price in the short term.
The earnings miss and year-over-year decline in EPS are likely to negatively impact investor sentiment, leading to a potential short-term decrease in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100